Brilinta Taiwan Post Approval Safety Study

Clinical trial NCT02406248 · COMPLETED

Trial details

NCT number

NCT02406248

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2015-04-23

Primary completion

2017-02-09

Enrollment

108

View on ClinicalTrials.gov